Thomas Dejoie

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results.

Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results.

Journal: Blood

Published: February 19, 2026

Dapagliflozin corrects hypomagnesemia in kidney-transplant patients.

Dapagliflozin corrects hypomagnesemia in kidney-transplant patients.

Journal: Journal of nephrology

Published: November 11, 2025

Improving fecal sample collection in patients with inflammatory bowel disease: A comparative evaluation of two calprotectin devices.

Improving fecal sample collection in patients with inflammatory bowel disease: A comparative evaluation of two calprotectin devices.

Journal: Clinics and research in hepatology and gastroenterology

Published: July 02, 2025

Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results.

Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results.

Journal: Blood

Published: November 12, 2024

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.

Journal: The Lancet. Oncology

Published: April 05, 2024

An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients.

An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients.

Journal: Clinical chemistry and laboratory medicine

Published: March 07, 2024

Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03.

Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03.

Journal: British journal of haematology

Published: January 05, 2024

Improved detection of tryptic immunoglobulin variable region peptides by chromatographic and gas-phase fractionation techniques.

Improved detection of tryptic immunoglobulin variable region peptides by chromatographic and gas-phase fractionation techniques.

Journal: Cell reports methods

Published: November 03, 2023

N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma.

N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma.

Journal: Clinical chemistry and laboratory medicine

Published: October 24, 2023

Evolution of Carboxyhemoglobin in Children Supported by Extracorporeal Membrane Oxygenation: An Observational Single-Center Study.

Evolution of Carboxyhemoglobin in Children Supported by Extracorporeal Membrane Oxygenation: An Observational Single-Center Study.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: August 01, 2023

M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.

M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.

Journal: Clinical chemistry and laboratory medicine

Published: July 24, 2023

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.

Journal: Blood cancer journal

Published: December 09, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026